Fosamax Label Change to Add Warning for Femur Fractures
This has been a long time coming! I have been actively involved in Fosamax litigation since 2006 and have lectured at numerous seminars on the subject. Back then, it was just osteonecrosis of the jaw (ONJ) on the radar. But soon after, a deeper, more ominous danger began to surface through internal Merck documents.
Read More
Hundreds of Fosamax Fracture Cases Reinstated
This week the Third Circuit Court of Appeals decided to reverse a ruling by U.S. District court Joel Pisano. Judge Pisano dismissed all federal court Fosamax cases on federal preemption grounds. The Third Court decided that whether the FDA would have rejected a Fosamax label change by the manufacturer, Merck to warn consumers about an
Read MoreNew Jersey Fosamax Femur Fracture Trials on the Horizon
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Things are certainly heating up in the pursuit of justice for the thousands of victims of Fosamax femur fracture injuries. I am excited to announce that the first Fosamax femur fracture trial is currently set to begin in March of 2013
Read MoreFDA Considers 5 Year Limit on Fosamax Use
This is a long time coming. It is about time that the FDA is finally coming around to the notion that long-term use of bisphosphonates like Fosamax is just a bad idea. The simple fact is that the longer a person uses Fosamax, the greater the likelihood that he/she will suffer from a severe, disabling
Read MoreConsumer Alert! Fosamax Linked to Esphogeal Cancer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Another serious safety concern with Fosamax! Can this drug get any worse in terms of a safety profile? Today FDA Communications issued a warning derived from a study from the UK General Practice Database that users of Fosamax of three years
Read More